204 related articles for article (PubMed ID: 37391593)
21. SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52.
Diao Y; Li Y; Wang Z; Wang S; Li P; Kong B
Cell Death Dis; 2022 Feb; 13(2):179. PubMed ID: 35210412
[TBL] [Abstract][Full Text] [Related]
22. Skipping Nonsense to Maintain Function: The Paradigm of
Meulemans L; Mesman RLS; Caputo SM; Krieger S; Guillaud-Bataille M; Caux-Moncoutier V; Léone M; Boutry-Kryza N; Sokolowska J; Révillion F; Delnatte C; Tubeuf H; Soukarieh O; Bonnet-Dorion F; Guibert V; Bronner M; Bourdon V; Lizard S; Vilquin P; Privat M; Drouet A; Grout C; Calléja FMGR; Golmard L; Vrieling H; Stoppa-Lyonnet D; Houdayer C; Frebourg T; Vreeswijk MPG; Martins A; Gaildrat P
Cancer Res; 2020 Apr; 80(7):1374-1386. PubMed ID: 32046981
[TBL] [Abstract][Full Text] [Related]
23. Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption.
Meyer S; Stevens A; Paredes R; Schneider M; Walker MJ; Williamson AJK; Gonzalez-Sanchez MB; Smetsers S; Dalal V; Teng HY; White DJ; Taylor S; Muter J; Pierce A; de Leonibus C; Rockx DAP; Rooimans MA; Spooncer E; Stauffer S; Biswas K; Godthelp B; Dorsman J; Clayton PE; Sharan SK; Whetton AD
Cell Death Dis; 2017 Jun; 8(6):e2875. PubMed ID: 28617445
[TBL] [Abstract][Full Text] [Related]
24. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
25. Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes.
Théry JC; Krieger S; Gaildrat P; Révillion F; Buisine MP; Killian A; Duponchel C; Rousselin A; Vaur D; Peyrat JP; Berthet P; Frébourg T; Martins A; Hardouin A; Tosi M
Eur J Hum Genet; 2011 Oct; 19(10):1052-8. PubMed ID: 21673748
[TBL] [Abstract][Full Text] [Related]
26. Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements.
Di Giacomo D; Gaildrat P; Abuli A; Abdat J; Frébourg T; Tosi M; Martins A
Hum Mutat; 2013 Nov; 34(11):1547-57. PubMed ID: 23983145
[TBL] [Abstract][Full Text] [Related]
27. Snrpb is required in murine neural crest cells for proper splicing and craniofacial morphogenesis.
Alam SS; Kumar S; Beauchamp MC; Bareke E; Boucher A; Nzirorera N; Dong Y; Padilla R; Zhang SJ; Majewski J; Jerome-Majewska LA
Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35593225
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
He X; Ee PL; Coon JS; Beck WT
Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
[TBL] [Abstract][Full Text] [Related]
29. Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons.
Acedo A; Hernández-Moro C; Curiel-García Á; Díez-Gómez B; Velasco EA
Hum Mutat; 2015 Feb; 36(2):210-21. PubMed ID: 25382762
[TBL] [Abstract][Full Text] [Related]
30. Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells.
Wang QE; Milum K; Han C; Huang YW; Wani G; Thomale J; Wani AA
Mol Cancer; 2011 Mar; 10():24. PubMed ID: 21385444
[TBL] [Abstract][Full Text] [Related]
31. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract][Full Text] [Related]
32. The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
Wei Y; Chen Z; Li Y; Song K
Oncogene; 2024 May; 43(20):1565-1578. PubMed ID: 38561505
[TBL] [Abstract][Full Text] [Related]
33. SNORA70E promotes the occurrence and development of ovarian cancer through pseudouridylation modification of RAP1B and alternative splicing of PARPBP.
Chen S; Li QH; Chen X; Bao HJ; Wu W; Shen F; Lu BF; Jiang RQ; Zong ZH; Zhao Y
J Cell Mol Med; 2022 Oct; 26(20):5150-5164. PubMed ID: 36056690
[TBL] [Abstract][Full Text] [Related]
34. Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer.
Jasiak A; Koczkowska M; Stukan M; Wydra D; Biernat W; Izycka-Swieszewska E; Buczkowski K; Eccles MR; Walker L; Wasag B; Ratajska M
Exp Mol Pathol; 2023 Apr; 130():104856. PubMed ID: 36791903
[TBL] [Abstract][Full Text] [Related]
35. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells.
Wan B; Dai L; Wang L; Zhang Y; Huang H; Qian G; Yu T
Endocr Relat Cancer; 2018 Jan; 25(1):69-82. PubMed ID: 29066501
[TBL] [Abstract][Full Text] [Related]
37. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
He X; Zhang P
Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
[TBL] [Abstract][Full Text] [Related]
38. Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling.
Pensabene M; Spagnoletti I; Capuano I; Condello C; Pepe S; Contegiacomo A; Lombardi G; Bevilacqua G; Caligo MA
Ann Oncol; 2009 May; 20(5):874-8. PubMed ID: 19179552
[TBL] [Abstract][Full Text] [Related]
39. [Regulatory effect of small nuclear ribonucleoprotein-associated protein B on proliferation and metastasis of liver cancer cells].
Li YR; Guo D; Chen DF; Lu GF; Ren MD; He SX
Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):63-68. PubMed ID: 35152671
[No Abstract] [Full Text] [Related]
40. Hypoxia-dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression.
Hirschfeld M; Zhang B; Jaeger M; Stamm S; Erbes T; Mayer S; Tong X; Stickeler E
Mol Carcinog; 2014 Nov; 53(11):883-92. PubMed ID: 23765422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
